Pharmaceutical Care for Chronic Obstructive Pulmonary Disease (COPD) Study.

Launched by UNIVERSITY HOSPITAL, GHENT · Dec 13, 2010

Keywords

ClinConnect Summary

Effective pharmacologic management of Chronic Obstructive Pulmonary Disease (COPD) not only involves prescription of recommended medicines by the physician, but also implies correct use of the prescribed medication by the patient (ie, good drug adherence and correct inhalation technique). Community pharmacists could help to improve the latter aspect, by delivering pharmaceutical care. The present randomised controlled trial will study the hypothesis that a pharmaceutical care intervention would result in an improved drug adherence and inhalation technique in COPD patients over a 3 month-per...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • daily use of Chronic Obstructive Pulmonary Disease (COPD)-medication: (Global initiative for chronic Obstructive Lung Disease: GOLD stadia I-IV)
• • 50 years of age or older
• • smoking history of at least 10 pack-years
• Exclusion Criteria:
• • having asthma
• • analphabetism

Trial Officials